title: Influence of propylthiouracil treatment on oxidative stress and nitric oxide in Basedow disease patients.
abstract: Oxidative stress parameters and nitric oxide (NO) values were determined in 27 newly diagnosed Basedow patients before and after 1 mo of propylthiouracil (PTU) therapy and in 15 healthy controls. Basedow patients exhibited increased triiodothyronine (T3) and thyroxine (T4) and decreased thyroid-stimulating hormone (TSH) values compared to controls. Significantly higher thiobarbituric acid-reactive substances (TBARS), NO and glutathione (GSH) levels, and CuZn superoxide dismutase (CuZn SOD) activity were found in Basedow patients in comparison to controls, regardless of sex. Treatment with PTU (3 x 100 mg/d for 30 d) was effective in decreasing T1 and T4 and increasing TSH levels. Significantly decreased NO and TBARS and increased GSH and CuZn SOD levels were observed in PTU-treated Basedow patients compared to pre-PTU administration. PTU-treated patients compared to controls still exhibited significantly higher T3 and lower TSH values and higher NO, TBARS, GSH, and CuZn SOD levels. The induced antioxidant defense and decrease in NO) values in response to PTU therapy emphasizes the role of PTU as an antithyroid drug, where the ability to diminish hyperthyroidism results in decreased catabolism and lower oxidant generation.
authors: Department of General Surgery, Istanbul Medical Faculty, Istanbul University, Turkey. bbseven@superonline.com.tr
authors: R
authors: R
authors: Seven
authors: R
authors: R
authors: Gelişgen
authors: A
authors: A
authors: Seven
authors: Y
authors: Y
authors: Erbil
authors: A
authors: A
authors: Bozbora
authors: G
authors: G
authors: Burçak
mesh_terms: D000328:Adult; D013956:Antithyroid Agents / Q000627:therapeutic use*; D004912:Erythrocytes / Q000378:metabolism; D005260:Female; D005978:Glutathione / Q000097:blood; D006111:Graves Disease / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology*; D006801:Humans; D008297:Male; D009569:Nitric Oxide / Q000378:metabolism*; D018384:Oxidative Stress / Q000187:drug effects*; D011441:Propylthiouracil / Q000627:therapeutic use*; D017392:Thiobarbituric Acid Reactive Substances / Q000378:metabolism; D013972:Thyrotropin / Q000097:blood; D013974:Thyroxine / Q000097:blood; D014284:Triiodothyronine / Q000097:blood
chemical_list: D013956:Antithyroid Agents; D017392:Thiobarbituric Acid Reactive Substances; D014284:Triiodothyronine; D009569:Nitric Oxide; D011441:Propylthiouracil; D013972:Thyrotropin; D005978:Glutathione; D013974:Thyroxine